- Trials with a EudraCT protocol (811)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (62)
811 result(s) found for: Neck.
Displaying page 1 of 41.
EudraCT Number: 2010-022794-34 | Sponsor Protocol Number: 862-P-201 | Start Date*: 2011-03-04 | |||||||||||
Sponsor Name:Novartis Consumer Health | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multi-center parallel group phase IV study to evaluate the efficacy and safety of Voltaren® Schmerzgel 1.16% gel in subjects with acute neck pain | |||||||||||||
Medical condition: Acute neck pain, present for at least 12 hours. An acute condition is defined as pain shorter than 3 months [CPMP, 2002]. Neck pain is defined as stiffness and/or pain felt dorsally in the cervical... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003707-18 | Sponsor Protocol Number: Evelien05 | Start Date*: 2014-04-22 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: Absorption of sublingual delivered fentanyl (Abstral®) in head and neck cancer patients treated with curatively aimed chemo-radiotherapy | |||||||||||||
Medical condition: head and neck cancer patients treated with chemo-radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001023-80 | Sponsor Protocol Number: 26 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Danish Head and Neck Cancer Group (DAHANCA) | |||||||||||||
Full Title: DAHANCA 26. A phase II unblinded, randomized study of paclitaxel and capecitabine with or without cetuximab as first line treatment of recurrent or metastatic squamous cell head and neck cancer (HN... | |||||||||||||
Medical condition: Recurrent or metastatic squamous cellular head and neck cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024046-29 | Sponsor Protocol Number: GEP 11/1010 | Start Date*: 2013-05-28 | |||||||||||
Sponsor Name:FNCLCC | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001641-40 | Sponsor Protocol Number: ESR-17-12933 | Start Date*: 2019-09-09 | ||||||||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | ||||||||||||||||||
Full Title: Induction Durvalumab (MEDI4736) & Radiotherapy (RT) for Locally Advanced but Resectable Head and Neck Squamous Cell Carcinomas: A Pilot Study | ||||||||||||||||||
Medical condition: Advanced resectable head and neck tumor | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001812-80 | Sponsor Protocol Number: 11-12-23/03-intern-6470 | Start Date*: 2011-11-25 | |||||||||||
Sponsor Name:Maastro Clinic | |||||||||||||
Full Title: Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer. | |||||||||||||
Medical condition: Patients with histological or cytological confirmed squamous cell carcinomas of the oral cavity, oropharynx, hypopharynx, larynx, T2-T3-T4, any N, M0 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017943-32 | Sponsor Protocol Number: 871 | Start Date*: 2010-05-31 | |||||||||||
Sponsor Name:Antwerp University Hospital | |||||||||||||
Full Title: Study of the combination of gemcitabine, cetuximab and radiotherapy in patients with head and neck cancer | |||||||||||||
Medical condition: Histologically confirmed squamous cell carcinoma of the head and neck which qualifies for definitive treatment with chemoradiation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002647-29 | Sponsor Protocol Number: ELECTROCHEMO-1 | Start Date*: 2014-02-12 | |||||||||||||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||||||||||||
Full Title: Clinical trial to evaluate the efficacy and tolerability of electrochemotherapy for palliative treatment in patients with head and neck squamous cell carcinoma | |||||||||||||||||||||||
Medical condition: head and neck squamous cell carcinoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002765-36 | Sponsor Protocol Number: IEO38 | Start Date*: 2014-03-23 | |||||||||||
Sponsor Name:Istituto Europeo di Oncologia | |||||||||||||
Full Title: SIB –IMRT using a modulated accelerated fractionation for head and neck cancer patients | |||||||||||||
Medical condition: head and neck squamous cell carcinoma eligible for a curative treatment with radiotherapy and Cetuximab | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013878-40 | Sponsor Protocol Number: 09.08 | Start Date*: 2009-08-24 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Phase II trial of Cetuximab in combination with chemotherapy (Carboplatinum and Navelbine) for patients with platinum-resistant head- and neckcancer | |||||||||||||
Medical condition: Platinum-resistant head and neck cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004712-32 | Sponsor Protocol Number: UC-0130/1106 | Start Date*: 2012-01-10 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: A PHASE II, OPEN-LABEL, MULTICENTER TRIAL OF CABAZITAXEL IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK CANCER AFTER FAILURE OF CISPLATIN, CETUXIMAB AND TAXANES. | |||||||||||||
Medical condition: Recurrent or metastatic head and neck cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000404-25 | Sponsor Protocol Number: 1358.1 | Start Date*: 2016-05-02 | ||||||||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||||||||||||||||||
Full Title: A randomized, controlled multi-centre parallel group study to assess the efficacy and safety of multiple doses of a topically applied combination containing diclofenac 2% + capsaicin 0.075% (2 g fo... | ||||||||||||||||||
Medical condition: Acute back pain or acute neck pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000078-36 | Sponsor Protocol Number: protocol2tdn | Start Date*: 2015-03-17 | |||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | |||||||||||||
Full Title: Analgetisk effekt af proksimal supplerende nervus obturatorius blokade efter insufficient analgetisk effekt af nervus femoralis blokade hos patienter med hoftenær femurfraktur | |||||||||||||
Medical condition: Pain in patients with hip fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014737-24 | Sponsor Protocol Number: 68GaPET-HNSCC-2009 | Start Date*: 2010-11-19 | |||||||||||
Sponsor Name:Medizinische Universität Innsbruck | |||||||||||||
Full Title: Vergleichende Studie zur Darstellung der Somatostatinrezeptoren bei Kopf-Hals-Tumoren mit Immunhistochemie und PET (68Ga-DOTA-Tyr3-Octreotid) | |||||||||||||
Medical condition: Patients suffering from head and neck squamous cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000023-33 | Sponsor Protocol Number: PIR-BO-11-001 | Start Date*: 2011-11-02 | |||||||||||
Sponsor Name:S.P.A. ITALIANA LABORATORI BOUTY | |||||||||||||
Full Title: Clinical trial to evaluate, in patient suffering of neck pain the therapeutic equivalence, tolerability and satisfaction of subjects treated by medicated plaster containing piroxicam or diclofenac. | |||||||||||||
Medical condition: cervical pain of osteoarthritic origin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013317-10 | Sponsor Protocol Number: GEN211 | Start Date*: 2009-12-15 | |||||||||||
Sponsor Name:Genmab A/S | |||||||||||||
Full Title: An Open-label, Multi-Center, Phase I/II Trial Investigating the Pharmacokinetic profile of Zalutumumab, a Human Monoclonal Epidermal Growth Factor Receptor Antibody in non-curable patients with SCCHN | |||||||||||||
Medical condition: Non-Curable Squamous cell carcinoma of the head and neck (SCCHN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) GB (Prematurely Ended) HU (Completed) SK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001928-29 | Sponsor Protocol Number: GORTEC2015-02 | Start Date*: 2015-07-07 | |||||||||||
Sponsor Name:GORTEC | |||||||||||||
Full Title: Phase II randomized trial comparating two concomitant administration of radiotherapy with cisplatin in patients with not operated or inoperable squamous cell carcinoma of the head and neck or with... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003636-36 | Sponsor Protocol Number: UCL/17/0396 | Start Date*: 2019-01-08 | ||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||
Full Title: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck | ||||||||||||||||||
Medical condition: Recurrent/metastatic head and neck squamous cell cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003592-64 | Sponsor Protocol Number: UCL/17/0560 | Start Date*: 2018-03-16 | ||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||
Full Title: A randomised phase II study evaluating the safety and anti-tumour activity of the combination of avelumab and cetuximab relative to avelumab monotherapy in recurrent/metastatic head and neck squamo... | ||||||||||||||||||
Medical condition: recurrent/metastatic head and neck squamous cell cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002168-14 | Sponsor Protocol Number: nano-MRI.H&N.1 | Start Date*: 2019-02-12 |
Sponsor Name:Radboudumc | ||
Full Title: Validation of USPIO-enhanced MRI for detection of lymph node metastases in head and neck carcinoma: a pilot study. | ||
Medical condition: Lymph node metastases in patients with squamous cell head and neck carcinoma. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.